Connect Biopharma Holdings Limited
CNTBDrugs in Pipeline
5
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Oct 2, 2026
13dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
Conference — ATTR
For ATTR amyloidosis. CNTB is hosting the 3rd Annual ATTR Early-Career Research Forum with a one-month deadline for abstract submissions. Two $100,000 Wiesman Awards will be granted to early-career ATTR researchers.
Source1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Acetaminophen
Patency of the Ductus Arteriosus
CBP-201
Moderate to Severe Persistent Asthma
Double-Blind 0.2mg CBP-307
Moderate to Severe Ulcerative Colitis
umbilical cord blood (hUCB) cells
Cerebral Palsy
Rademikibart
Asthma Acute
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Acetaminophen | Phase 3 | Patency of the Ductus Arteriosus | - | - |
CBP-201 | Phase 2 | Moderate to Severe Persistent Asthma | - | - |
Double-Blind 0.2mg CBP-307 | Phase 2 | Moderate to Severe Ulcerative Colitis | - | - |
umbilical cord blood (hUCB) cells | Phase 2 | Cerebral Palsy | - | - |
Rademikibart | Phase 2 | Asthma Acute | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Connect Biopharma Holdings Limited's drug pipeline?→
CatalystAlert tracks 5 drug candidates in Connect Biopharma Holdings Limited's (CNTB) pipeline across Phase 3, Phase 2. Its lead program is Acetaminophen (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Connect Biopharma Holdings Limited's next FDA catalyst?→
Connect Biopharma Holdings Limited's (CNTB) next tracked catalyst is a Conference expected October 2, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CNTB biotech catalysts?→
Add CNTB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Connect Biopharma Holdings Limited's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.